Head-to-head comparison of two commonly prescribed ADHD stimulants found comparable symptom response but differences in weight outcomes over 12 months. Study: A Randomised Open-Label Comparison of ...
Medications comparable in terms of symptom response and adherence, but weight loss greater with dexamphetamine. HealthDay News — For children and adolescents with ...
VIENNA, Austria — Prescription drugs designed to boost cognition in neurodevelopmental disorders do not increase overall cognitive performance in healthy individuals — and may even reduce productivity ...
Use of dexamphetamine, lisdexamphetamine, and methylphenidate was associated with a reduced risk for suicidal behavior (adjusted hazard ratios, 0.69, 0.76, and 0.92, respectively). Amphetamine, ...
Ritalin is the most common brand name for methylphenidate, a stimulant used to treat attention deficit hyperactivity disorder (ADHD). Pharmaceutical company Novartis owns the name Ritalin, but ...
Attention-deficit/hyperactivity disorder (ADHD), which causes affected individuals to be impulsive, hyperactive, or inattentive, is typically treated with medications ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results